OTC
AGIO icon

Opera Trading Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Opera Trading Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,847
Closed -$374K – 91
2018
Q3 		$374K Buy
+4,847
New +$390K 0.07% 90
2016
Q3 		– Sell
-570
Closed -$24K – 113
2016
Q2 		$24K Sell
570
-1,230
-68% -$60.7K 0.01% 116
2016
Q1 		$73K Buy
+1,800
New +$77K 0.02% 113

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Opera Trading Capital's AGIO Position: Q4 2018 in Review

Opera Trading Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 4,847 shares — an estimated $374K sold.

Opera Trading Capital first reported a position in AGIO in Q1 2016 and held it in 3 quarters. The position peaked at $374K in Q3 2018. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

  • Opera Trading Capital reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Opera Trading Capital sold 4,847 Agios Pharmaceuticals shares in Q4 2018, an estimated $374K.
  • Opera Trading Capital first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • Opera Trading Capital's Agios Pharmaceuticals position peaked at $374K in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on Opera Trading Capital's 13F filing for Q4 2018, filed 22 Jan 2019.